ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

ClinicalTrials.gov ID: NCT00868959

Public ClinicalTrials.gov record NCT00868959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression

Study identification

NCT ID
NCT00868959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
817 participants

Conditions and interventions

Interventions

  • lurasidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Jan 31, 2013
Completion
Jan 31, 2013
Last update posted
Apr 13, 2016

2009 – 2013

United States locations

U.S. sites
58
U.S. states
20
U.S. cities
52
Facility City State ZIP Site status
Woodland International Research Inc Little Rock Arkansas 72211
South Coast Clinical Trials Inc. Anaheim California 92804
Catalina Research Institute Chino California 91710
Clinical Innovations Inc. Costa Mesa California 92626
Synergy Escondido Escondido California 92025
Collaborative Neuroscience Network Inc Garden Grove California 92645
Cedars-Sinai Medical Center Los Angeles California 90048
Florida Clinical Research Center LLC Maitland California 32751
Excell Research, Inc Oceanside California 92056
University of California at Irvine Medical Center Orange California 92868
CNRI - Los Angeles LLC Pico Rivera California 90660
Clinical Innovations Inc. Riverside California 92506
California Neuropsychopharmacology Clinical Research Instit San Diego California 92102
Artemis Institute for Clinical Research LLC San Diego California 92123
Sharp Mesa Vista Hospital San Diego California 92123
Clinical Innovations Inc. Santa Ana California 92705
Stanford University School of Medicine Stanford California 94305
Collaborative Neuroscience Network Inc. Torrance California 90502
University of Colorado Aurora Colorado 80045
MCB Clinical Research Centers-Colorado Springs Colorado Springs Colorado 80917
Florida Clinical Research Center LLC Bradenton Florida 34208
Florida Clinical Research Center LLC Fruitland Park Florida 34731
Accurate Clinical Trials Kissimmee Florida 34741
Clinical Neuroscience Solutions INc. Orlando Florida 32806
University of South Florida Institute - Tampa Tampa Florida 33613
Janus Center for Psychiatric Research West Palm Beach Florida 33407
Northwest Behavioral Research Center Rosewekk Georgia 30076
Institute for Behavioral Medicine LLC Smyrna Georgia 30080
American Medical Research Oak Brook Illinois 60523
Lake Charles Clinical Trials LLC Lake Charles Louisiana 70601
Booker, J. Gary, MD. APMC Shreveport Louisiana 71104
Sheppard Pratt Health System Baltimore Maryland 21285
Capitol Clinical Research Rockville Maryland 20852
Precise Research Centers Flowood Mississippi 39232
Midwest Research Group Saint Charles Missouri 63301
CRI Worldwide, LLC Willingboro New Jersey 08046
Albuquerque Neuroscience Inc. Albuquerque New Mexico 87109
Social Psychiatry Research Institute Brooklyn New York 11235
Neurobehavioral Research, Inc Cedarhurst New York
Village Clinical Research Inc. New York New York 10003
Medical & Behavioral Health Research PC New York New York 10023
Finger Lakes Clinical Research Rochester New York 14618
Zarzar Psychiatric Associates PLLC Raleigh North Carolina 27607
Richard H. Weisler & Associates Raleigh North Carolina 27609
Quest Therapeutics Avon Lake Ohio 44012
Psychiatric Professional Services Inc Cincinnati Ohio 45267
Mood Disorders Program-UHCMC Cleveland Ohio 44106
MetroHealth System Cleveland Ohio 44122
Midwest Clinical Research Center Dayton Ohio 45408
Summit Research Network (Oregon) Inc. Portland Oregon 97210
Lehigh Valley Hospital Allentown Pennsylvania 18103
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
FutureSearch Clinical Trials LP Austin Texas 78756
FutureSearch Trials Dallas Texas 75231
Pillar Clinical Research LLC Dallas Texas 75243
Red Oak Psychiatry Associates, PA Houston Texas 77090
Wharton Research Center Wharton Texas 77488
Summit Research Network (Seattle) LLC Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 93 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00868959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2016 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00868959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →